Overall Technical outlook

Price Summary

Piramal Pharma Limited's stock began trading at 220.3 on 2025-04-25, soared to 222.0, dipped to 212.58, and finished the day -1.84% down at 216.25, with 3966490 shares exchanged.
During the 52-week span, the stock hit a high of 293.55 and a low of 142.25.
10 analysts estimate that the future price of PPLPHARMA will fall between 255.0 and 340.0, with an average price expectation of approximately 296.0.

Technicals

Support and Resistance: The current price for PPLPHARMA is 216.25, supported at 190.75 with resistance at 218.79. This indicates a trading range where 190.75 might prevent further declines, while 218.79 could hinder additional gains.
PPLPHARMA supportResistance 18c259
Support/Resistance for PPLPHARMA


Aroon: The AROON is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
PPLPHARMA aroon 18c259
Aroon chart for Piramal Pharma Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
PPLPHARMA bbands 18c259
Bolinger Bands chart for Piramal Pharma Limited


Parabolic SAR: The PSAR continues its bearish outlook, setting a key resistance level that could limit upward potential. This resistance suggests that the market may struggle to break higher, reflecting ongoing bearish pressure for PPLPHARMA.
PPLPHARMA psar 18c259
Parabolic Stop and Reverse chart for Piramal Pharma Limited


Stochastic: The current reading of the STOCHASTIC is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
PPLPHARMA stoch 18c259
Stochastic chart for Piramal Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
PPLPHARMA trippleSMA 18c259
Tripple SMA chart for Piramal Pharma Limited


When assessing a company's technical performance, such as stock price fluctuations and trading volume, it is crucial to first examine its fundamentals. These fundamentals include financial health, profitability, and growth potential. Additionally, understanding the industry's dynamics, including competitive pressures and market trends, is key to contextualizing the company's performance. By integrating these factors, a more comprehensive and meaningful analysis can be conducted, leading to more informed investment decisions.